Exponent Inc (EXPO) Stock Forecast Nov. 6, 2026
Analysis updated on Nov. 6, 2026 (UTC) · Alpha · vs marketSwitch to Total · Nasdaq
Exponent Inc (EXPO) stock forecast summary
Our AI scores Exponent Inc every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
Exponent Inc is a mid-cap company with a market capitalization of $4.08B. It ranks number 5 by market capitalization among the 35 Services-Management Consulting Services issuers in our coverage with a current forecast.
For EXPO, the Spearman rank correlation between our 90-day forecasts and the returns that followed is -1.0%, measured on 357 forecast dates between 2022-08-19 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 6.0%, measured on 400 forecast dates between 2022-08-19 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +3.1%, buy ≥ +1.5%, sell < -0.5%, strong sell < -1.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-11-06 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, EXPO included.
EXPO price chart and AI forecast
How EXPO ranks among 5150 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Exponent Inc (EXPO) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Services-Management Consulting Services peers listed below that report each metric.
Valuation & Market
| Metric | EXPO | Rank |
|---|---|---|
| Market Cap | $4.08B | 5/35 |
| P/E Ratio | 39.92x | 3/15 |
| P/B Ratio | 14.14x | 3/28 |
| Dividend Yield | 1.50% | 5/8 |
| EPS | $2.15 | – |
| Book Value/Share | $6.07 | – |
| Revenue/Share | $13.30 | – |
| FCF/Share | $2.28 | – |
Profitability & Margins
| Metric | EXPO | Rank |
|---|---|---|
| ROE | 38.7% | 2/15 |
| ROA | 17.1% | 1/19 |
| ROIC | 25.8% | 4/26 |
| Operating Margin | 20.2% | 2/26 |
| Net Margin | 17.7% | 2/17 |
| EBT Margin | 24.6% | 2/28 |
| Tax Rate | 28.3% | – |
Financial Health
| Metric | EXPO | Rank |
|---|---|---|
| Current Ratio | 1.98x | 11/31 |
| D/E Ratio | 1.26x | 8/29 |
| Financial Leverage | 2.26x | 8/28 |
| Working Capital | $154M | 7/31 |
Cash Flow
| Metric | EXPO | Rank |
|---|---|---|
| Operating Cash Flow | $118M | 7/35 |
| Free Cash Flow | $109M | 6/17 |
| Capital Spending | -$10M | 7/17 |
| OCF Growth YoY | -8.6% | 8/15 |
| FCF Growth YoY | -10.2% | 6/15 |
| FCF/Sales | 17.2% | 1/17 |
| CapEx/Sales | 1.5% | 5/17 |
Operational Efficiency
| Metric | EXPO | Rank |
|---|---|---|
| Asset Turnover | 0.97x | 10/21 |
| Receivables Turnover | 2.9x | 19/19 |
| Fixed Assets Turnover | 8.9x | 16/19 |
| Days Sales Outstanding | 126 days | 1/19 |
Income Statement
| Metric | EXPO | Rank |
|---|---|---|
| Total Revenue | $632M | 9/23 |
| Operating Income | $128M | 6/32 |
| Net Income | $112M | 5/22 |
Dividend & Shareholder Information
| Metric | EXPO | Rank |
|---|---|---|
| Dividends Per Share | $1.29 | – |
| Payout Ratio | 60.0% | 4/7 |
| Shares Outstanding | 48M | – |
| Net Income Growth | 8.7% | 4/13 |
| EPS Growth | 4.4% | 4/12 |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $312M | 47.8% of assets |
| Cash & Short-term Investments | $67M | 10.2% of assets |
| Accounts Receivable | $218M | 33.5% of assets |
| Total Liabilities | $364M | 55.8% of assets |
| Short-term Debt | $131M | 20.1% of assets |
EXPO quarterly financials and insider trading
Exponent Inc (EXPO) industry peers
Companies classified under the same SEC industry code as Exponent Inc (Services-Management Consulting Services): 39 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| EXPO Exponent Inc | $4.08B | |
| GIB Cgi Inc | $18.33B | |
| BAH Booz Allen Hamilton Holding Corp | $10.12B | |
| G Genpact Ltd | $7.10B | |
| FCN Fti Consulting, Inc | $5.34B | |
| HURN Huron Consulting Group Inc. | $2.77B | |
| ASTH Astrana Health, Inc. | $1.92B | |
| ICFI Icf International, Inc. | $1.43B | |
| ONT Onterris, Inc. | $770M | |
| BWMN Bowman Consulting Group Ltd. | $745M | |
| RMR Rmr Group Inc. | $500M | |
| ROMA Roma Green Finance Ltd | $373M | |
| PPHC Public Policy Holding Company, Inc. | $338M | |
| HCKT Hackett Group, Inc. | $330M | |
| III Information Services Group Inc. | $287M | |
| TSSI Tss, Inc. | $168M | |
| AUC Atif Holdings Ltd | $138M | |
| PHCI Panamera Holdings Corp | $120M | |
| RTB Rtb Digital, Inc. | $83M | |
| MHH Mastech Digital, Inc. | $77M | |
| CFOR Capforce Inc. | $75M | |
| NORD Nordicus Partners Corp | $62M | |
| BLNC Balance Labs, Inc. | $52M | |
| VDTA Vertical Data Inc. | $48M | |
| EUBG Entrepreneur Universe Bright Group | $46M | |
| CTM Castellum, Inc. | $45M | |
| AERT Aeries Technology, Inc. | $29M | |
| RYOJ Ryojbaba Co., Ltd. | $27M | |
| ACCS Access Newswire Inc. | $13M | |
| GRNQ Greenpro Capital Corp. | $13M | |
| PBSV Pharma-Bio Serv, Inc. | $10M | |
| LICN Lichen International Ltd | $10M | |
| CISO Ciso Global, Inc. | $7M | |
| DFNS T3 Defense Inc. | $7M | |
| GLVT Greenlit Ventures Inc. | $60K | |
| GXXM Gex Management, Inc. | N/A | |
| IVHI Invech Holdings, Inc. | N/A | |
| SATT Sativus Tech Corp. | N/A | |
| WYGC Wenyuan Group Corp. | N/A |
Where EXPO sits on the market map
Exponent Inc (EXPO) stock news
Loading...
Exponent Inc (EXPO) stock forecast FAQ
What is the Exponent Inc (EXPO) stock forecast?
Our AI scores Exponent Inc every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
How accurate are Exponent Inc stock predictions?
For EXPO, the Spearman rank correlation between our 90-day forecasts and the returns that followed is -1.0%, measured on 357 forecast dates between 2022-08-19 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 6.0%, measured on 400 forecast dates between 2022-08-19 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Exponent Inc forecasts updated?
Exponent Inc forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Nov. 6, 2026.
Which companies are Exponent Inc's industry peers?
39 issuers in our coverage, EXPO included, share the SEC industry code Services-Management Consulting Services. The largest are: Cgi Inc (GIB), Booz Allen Hamilton Holding Corp (BAH), Genpact Ltd (G), Fti Consulting, Inc (FCN), Huron Consulting Group Inc. (HURN), Astrana Health, Inc. (ASTH).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.